310 Risk should be addressed through pre-operative screening and longitudinal monitoring, particularly in individuals with prior substance use and mental health disorders
Animal studies have shown that GLP-1 receptors are present on bone cells, including osteoblasts and osteoclasts, suggesting a potential direct effect on bone metabolism, though the clinical relevance in humans remains uncertain
The two drugs work through entirely different mechanismsWegovy affects appetite regulation and gastric emptying, whilst levothyroxine replaces deficient thyroid hormoneand there is no direct pharmacological interaction between semaglutide and levothyroxine that would prevent their combined use
When to Contact Your Doctor About This Combination Notify your prescribing physician immediately if you experience elevated blood sugar readings, severe appetite increase, dizziness, or unexplained weight gain after starting prednisone while on semaglutide
Quick Answer: GLP-1 receptor agonists are being investigated for potential neuroprotective effects in Alzheimer's disease, but they are not FDA-approved for dementia prevention or treatment
A double blinded placebo controlled study using daily Orfoglipron (45 mg) in obese patients, found an average of 12.4% decrease in body weight over placebo after 36 weeks